tirzepatide and menopause New research presented at ENDO 2025 suggests that combining (Mounjaro) with hormone replacement therapy (HRT) may significantly boost weight loss in postmenopausal women living with overweight or obesity. In a real-world perimenopause and tirzepatide If you're

Phase 2 trials used up to 12 mg/week and produced 24.2% body weight loss at 48 weeks community protocols are deliberately more conservative

That difference fundamentally impacts how well the medication suppresses appetite and controls blood sugar

Novo Nordisk, the manufacturer of the Wegovy pill, explains that one of the main barriers to creating an effective GLP-1 pill was finding a way for the drug to survive the digestive process

(2019) suggests that minimizing ultra-processed foods, which are engineered to be hyperpalatable and may dysregulate appetite signaling, can reduce food preoccupation over time and lead to spontaneous reduction in calorie intake